The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease

Abstract

Stool studies yielded a pathogen, mainly C. difficile, in 20% of the relapsing IBD patients. Antibiotic use was significantly associated with a positive C. difficile toxin. Toxin-positive patients improved clinically with targeted antibiotics.